SE8501614D0 - Solubiliserbar, fibrinbaserad komposition och anvendning derav - Google Patents

Solubiliserbar, fibrinbaserad komposition och anvendning derav

Info

Publication number
SE8501614D0
SE8501614D0 SE8501614A SE8501614A SE8501614D0 SE 8501614 D0 SE8501614 D0 SE 8501614D0 SE 8501614 A SE8501614 A SE 8501614A SE 8501614 A SE8501614 A SE 8501614A SE 8501614 D0 SE8501614 D0 SE 8501614D0
Authority
SE
Sweden
Prior art keywords
fibrin
composition
pct
desaa
arginyl
Prior art date
Application number
SE8501614A
Other languages
English (en)
Other versions
SE447579B (sv
SE8501614L (sv
Inventor
M G Ranby
Original Assignee
Biopool Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20359734&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8501614(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biopool Ab filed Critical Biopool Ab
Priority to SE8501614A priority Critical patent/SE447579B/sv
Publication of SE8501614D0 publication Critical patent/SE8501614D0/sv
Priority to EP86902552A priority patent/EP0216891B1/en
Priority to AT86902552T priority patent/ATE50002T1/de
Priority to US06/936,347 priority patent/US4957903A/en
Priority to PCT/SE1986/000144 priority patent/WO1986005814A1/en
Priority to DE8686902552T priority patent/DE3668643D1/de
Publication of SE8501614L publication Critical patent/SE8501614L/sv
Publication of SE447579B publication Critical patent/SE447579B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE8501614A 1985-04-01 1985-04-01 Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar SE447579B (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8501614A SE447579B (sv) 1985-04-01 1985-04-01 Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar
EP86902552A EP0216891B1 (en) 1985-04-01 1986-03-27 A solubilizable, fibrin based composition and its use
AT86902552T ATE50002T1 (de) 1985-04-01 1986-03-27 Loesbare auf fibrin basierte zusammensetzung und deren verwendung.
US06/936,347 US4957903A (en) 1985-04-01 1986-03-27 Pharmaceutical and clinical compositions of desAA fibrin monomers and the tetrapeptide gly-pro-arg-pro
PCT/SE1986/000144 WO1986005814A1 (en) 1985-04-01 1986-03-27 A solubilizable, fibrin based composition and its use, in determinations of fibrinolysis parameters
DE8686902552T DE3668643D1 (de) 1985-04-01 1986-03-27 Loesbare auf fibrin basierte zusammensetzung und deren verwendung.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8501614A SE447579B (sv) 1985-04-01 1985-04-01 Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar

Publications (3)

Publication Number Publication Date
SE8501614D0 true SE8501614D0 (sv) 1985-04-01
SE8501614L SE8501614L (sv) 1986-10-02
SE447579B SE447579B (sv) 1986-11-24

Family

ID=20359734

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501614A SE447579B (sv) 1985-04-01 1985-04-01 Solubiliserbar, fibrinbaserad komposition och anvendning av kompositionen vid bestemning av fibrinolysparametrar

Country Status (5)

Country Link
US (1) US4957903A (sv)
EP (1) EP0216891B1 (sv)
DE (1) DE3668643D1 (sv)
SE (1) SE447579B (sv)
WO (1) WO1986005814A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1324748C (en) * 1987-07-06 1993-11-30 Mats Gustaf Ranby Assays for t-plasminogen activator and plasminogen activator inhibitor
FI89634C (sv) * 1987-07-10 1993-10-25 Yamanouchi Pharma Co Ltd Förfarande, anordning och kitt för mätning av vävnadsplasminogenaktiva tor-aktivitet
US5320945A (en) * 1989-07-14 1994-06-14 Boehringer Mannheim Gmbh Method and reagent for the determination of antithrombin III
JPH04233458A (ja) * 1990-08-23 1992-08-21 New York Blood Center Inc 可溶性フィブリン様モノマーを使ったアッセイ
DK0641222T3 (da) * 1992-05-21 2000-12-11 Diatide Inc Peptider mærket med technetium-99m til trombeafbildning
US5968476A (en) * 1992-05-21 1999-10-19 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
WO1997002291A1 (en) * 1995-06-30 1997-01-23 American Biogenetic Sciences, Inc. Method of producing fibrin-specific antibodies using soluble fibrin polymers as an immunogen
AU7353300A (en) 1999-09-08 2001-04-10 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
FR2813395B1 (fr) 2000-08-28 2003-01-24 Stago Diagnostica Methode de dosage in vitro de la fibrine soluble par generation de produits de degradation specifiques
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US6593362B2 (en) 2001-05-21 2003-07-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
WO2006001523A1 (ja) * 2004-06-24 2006-01-05 Tobishi Pharmaceutical Co., Ltd. Des A フィブリンを含有する悪性腫瘍抑制剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966701A (en) * 1973-11-07 1976-06-29 The Dow Chemical Company Fibrinogen peptide derivatives
US4455290A (en) * 1981-04-02 1984-06-19 Research Corporation Inhibition of fibrin polymerization by a peptide isolated from fibrin Fragment D1

Also Published As

Publication number Publication date
SE447579B (sv) 1986-11-24
EP0216891A1 (en) 1987-04-08
WO1986005814A1 (en) 1986-10-09
EP0216891B1 (en) 1990-01-31
DE3668643D1 (de) 1990-03-08
US4957903A (en) 1990-09-18
SE8501614L (sv) 1986-10-02

Similar Documents

Publication Publication Date Title
SE8501614D0 (sv) Solubiliserbar, fibrinbaserad komposition och anvendning derav
Studdy et al. Angiotensin-converting enzyme and its clinical significance--a review.
DE69903898T2 (de) Teststreifen zur visuellen Ermittlung der Blutglukose-Konzentration
ATE275583T1 (de) KALLIKREINHEMMENDE ßKUNITZ-DOMÄNEß-PROTEINE UND DERIVATEN DAVON
NO922149L (no) Fremgangsmaater for paavisning av kollagen-nedbrytning in vivo
BR9508151A (pt) Oligopeptídeo testes para determinar a atividade proteolítica de antígeno livre específico para próstata em uma amostra e para identificar compostos que inibem atividade proteolítica de antígeno específico para próstata e conjugado
CA2366682A1 (en) Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
NO920125D0 (no) Fremgangsmaate for aa bestemme den funksjonelle aktivitetentil fri protein s eller protein c i en plasma-proeve
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
ES8607262A1 (es) Esteres de aminoacidos y de peptidos cromogenos
DE60032784D1 (de) Markerproteine für prostatakrebs
GB1533205A (en) Plasmin fractions and complexes thereof
Walsh et al. Neuropeptide degrading enzymes in normal and inflamed human synovium.
ATE216495T1 (de) Diagnostisches verfahren für atherosklerosis
ATE24917T1 (de) Peptide-derivate, deren herstellung und verwendung als elastasehemmende mittel.
Giraldi et al. Lysosomal enzyme inhibitors and antimetastatic activity in the mouse
DK0931265T3 (da) Diagnistisk metode for aterosklerose
Zacharski et al. Cellular localization of activated factor X by Xa-specific probes
ES2159324T3 (es) Ensayo.
Caporale et al. A fluorescent assay for complement activation.
DE68911574D1 (de) Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür.
Yoshida et al. A novel function of extraerythrocytic hemoglobin
Grant et al. Catalytically active enterokinase in human bile
Furihata et al. A new fluorescent microassay method for pepsin using succinyl-albumin
Hiroyuki et al. Studies on kallikrein-kinin system in plasma of patients with acute pancreatitis

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8501614-5

Effective date: 19911108

Format of ref document f/p: F